⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
Latest News
Cognition Therapeutics to Report Fourth Quarter and Year End 2025 Financial Results
globenewswire.com
CGTX
Anavex Life Sciences Presents New Data from its AD-004 Phase IIb/III Trial at AD/PD 2026 Conference Demonstrating Consistent Correlation Between the Treatment Effect of Oral Blarcamesine and Preservation of Brain Volume in Early Alzheimer’s Disease
globenewswire.com
AVXL
Lexicon Pharmaceuticals and Novo Nordisk Announce initiation of Phase 1 study with oral obesity drug candidate LX9851
globenewswire.com
LXRX
Cognition Therapeutics to Report Fourth Quarter and Year End 2025 Financial Results
globenewswire.com
CGTX
SL Green Realty Corp. Announces Annual Ordinary Dividend of $2.47 per Share
globenewswire.com
SLG
Arbutus Reports Fourth Quarter and Year End 2025 Financial Results and Provides Corporate Update
globenewswire.com
ABUS
MRNA
ALNY
BNTX
SL Green Realty Corp. Announces Annual Ordinary Dividend of $2.47 per Share
globenewswire.com
SLG
ASP Isotopes Completes Well Drilling Required for Phase 1 of Renergen Helium Project Four Months Ahead of Schedule
globenewswire.com
ASPI
Palvella Therapeutics Strengthens Leadership Team with Appointment of Rare Disease Commercial Leader Jennifer J. McDonough as Senior Vice President of Market Access and Patient Services
globenewswire.com
PVLA
KRYS
Mobileye Secures Major DMS Production Program with Leading U.S. Automaker
businesswire.com
MBLY
INTC